Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2022-03-23 Investor Presentation
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Broker Briefing Investor Webinar Presentation 15 pages 2.6MB
Investor Presentation Classification · 95% confidence The document is titled 'Broker Briefing Investor Webinar Presentation' and includes detailed company overview, product descriptions, market analysis, sales development, and shareholder information. It is presented as an investor presentation delivered during a webinar on 24 March 2022. The text explicitly states that a copy of the investor presentation is attached, and the content is consistent with a presentation format rather than a formal report like an annual or quarterly report. There are no financial statements or detailed financial results included, which rules out Annual Report (10-K) or Interim Report (IR). The document is not an announcement of voting results, management changes, or legal proceedings. It is clearly an investor presentation aimed at providing financials, strategy, and market position to investors. Therefore, the correct classification is Investor Presentation (IP). The document length (15,000 characters) and content support a confident classification.
2022-03-23 English
Broker Briefing Investor Webinar 2 pages 47.5KB
Investor Presentation Classification · 90% confidence The document is an ASX release announcing a Broker Briefing Investor Webinar scheduled for a future date. It contains no financial statements, no detailed financial data, and no report content. The document is short (3005 characters) and serves as an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, it fits best under Investor Presentation (IP) category as it relates to a presentation for investors focusing on financials, strategy, and market position, even though the actual presentation is to be held later. Confidence is high due to clear identification as an investor webinar announcement.
2022-03-21 English
Nanoveu Launches Disinfection Robot Under a RaaS Model 62 pages 3.7MB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing the launch of a new product, the Nanoshield Bot, a disinfection robot under a Robot as a Service (RaaS) model. It includes product highlights, market potential, trial results, and business model details. The document also contains appended test reports related to the product's safety and efficacy, including acute oral toxicity tests and antiviral efficacy tests. There are no financial statements, earnings data, or management discussion of financial results. The document is primarily a corporate announcement about a new product launch and business model, not a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information about the product launch and business strategy. Therefore, the most appropriate classification is a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2022-03-15 English
Pause in Trading 1 page 111.7KB
Regulatory Filings Classification · 100% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It is very short (338 characters) and does not contain any financial data, report content, or detailed information. It is an official regulatory announcement related to trading status, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-03-14 English
Trading Halt 2 pages 496.4KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Nanoveu Limited requesting a trading halt pending the release of a sales and product update announcement. It is a short notice about the trading halt and does not contain any financial data, report content, or detailed disclosures. It is not a report itself but an announcement related to trading status. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2022-03-14 English
Nanoshield Accepted as Medical Device in the UK 2 pages 80.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing that Nanoveu Limited's Nanoshield antiviral film product has been accepted as a Class I medical device by the UK Medicines and Healthcare products Regulatory Agency (MHRA). It is a company announcement about regulatory approval and marketing capability, not a financial report, earnings release, or detailed management discussion. The document is relatively short (4117 characters) and serves as a news release rather than a formal report or filing. There is no financial data, no voting results, no management changes, no audit information, and no detailed investor presentation. Therefore, the document fits best into the category of a Regulatory Filing (RNS), which is the fallback for general regulatory announcements and compliance-related news that do not fit other categories.
2022-03-08 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.